Danielle Elyse Antin-Ozerkis MD

Associate Professor of Medicine (Pulmonary)

Departments & Organizations

Yale Medical Group

Office of Student ResearchInternal Medicine: Pulmonary, Critical Care & Sleep Medicine: Winchester Chest Clinic

Research Interests

Connective tissue disease/autoimmune disease associated interstitial lung disease; Genetics of interstitial lung diseases; Lung transplantation more...


  • B.A., Princeton University, 1990
  • M.D., University of Pennsylvania Medical School, 1999

Selected Publications

  • A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA; The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet). Am J Respir Crit Care Med. 2012 May 3. (Investigator)
  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomized trials. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group. Lancet. 2011 May 21;377(9779):1760-9. Epub 2011 May 13. (Investigator)
  • Antin-Ozerkis D and Gulati M. Cryptogenic Organizing Pneumonia. Clinical Decision Support in Medicine. 2012 In Press



Latest News


Edit Profile